Value of a short non-contrast CMR protocol in MINOCA.

Chest pain MINOCA Myocardial infarction Myocarditis Takotsubo cardiomyopathy

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 08 02 2023
accepted: 30 05 2023
revised: 24 04 2023
medline: 15 8 2023
pubmed: 15 8 2023
entrez: 15 8 2023
Statut: aheadofprint

Résumé

To evaluate the diagnostic performance of a short non-contrast CMR (ShtCMR) protocol relative to a matched standard comprehensive CMR (StdCMR) protocol in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA). This multicenter retrospective study included patients with a working diagnosis of MINOCA who underwent a StdCMR between January 2019 and December 2020. An expert and a non-expert reader performed a blinded reading with the ShtCMR (long-axis cine images, T2w-STIR, T1- and T2-mapping). A consensus reading of the StdCMR (reference standard) was performed at least 3 months after the ShtCMR reading session. Readers were asked to report the following: (1) diagnosis; (2) level of confidence in their diagnosis with the ShtCMR; (3) number of myocardial segments involved, and (4) functional parameters. A total of 179 patients were enrolled. The ShtCMR lasted 21 ± 9 min and the StdCMR 45 ± 11 min (p < 0.0001). ShtCMR allowed reaching the same diagnosis as StdCMR in 85% of patients when interpreted by expert readers (rising from 66% for poor confidence to 99% for good, p = 0.0001) and in 73% (p = 0.01) by non-expert ones (60% for poor vs 89% for good confidence, p = 0.0001). Overall, the ShtCMR overestimated the ejection fraction, underestimated cardiac volumes (p < 0.01), and underestimated the number of segments involved by pathology (p = 0.0008) when compared with the StdCMR. The ShtCMR was found to be a debatable alternative to the StdCMR in patients with MINOCA. Nevertheless, when an experienced reader reaches a good or very good diagnostic confidence using the ShtCMR, the reader may choose to stop the examination, reducing the length of the CMR without affecting the patient's diagnosis. A short non-contrast CMR protocol may be a viable alternative to standard protocols in selected CMR studies of patients with MINOCA, allowing for faster diagnosis while reducing time and resources and increasing the number of patients who can be scanned. • The ShtCMR lasted 21 ± 9 min and the StdCMR 45 ± 11 min (p < 0.0001). • In 57% of patients with MINOCA, the experienced reader considers that contrast medium is probably not necessary for diagnosis without affecting the patient's diagnosis (99% of agreement rate between ShtCMR and StdCMR).

Identifiants

pubmed: 37581660
doi: 10.1007/s00330-023-10096-2
pii: 10.1007/s00330-023-10096-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Bhatt DL, Lopes RD, Harrington RA (2022) Diagnosis and treatment of acute coronary syndromes: a review. JAMA 327:662–675
doi: 10.1001/jama.2022.0358 pubmed: 35166796
Palmisano A, Vignale D, Tadic M, et al (2022) Myocardial late contrast enhancement CT in troponin-positive acute chest pain syndrome. Radiology 302:545–553
Collet J-P, Thiele H, Barbato E et al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367
doi: 10.1093/eurheartj/ehaa575 pubmed: 32860058
De Ferrari GM, Fox KAA, White JA et al (2014) Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. Eur Heart J Acute Cardiovasc Care 3:37–45
doi: 10.1177/2048872613489315 pubmed: 24562802 pmcid: 3932771
Gulati M, Levy PD, Mukherjee D et al (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 144:e368–e454
pubmed: 34709928
Pathik B, Raman B, Mohd Amin NH et al (2016) Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 17:1146–1152
doi: 10.1093/ehjci/jev289 pubmed: 26590396
Dastidar AG, Baritussio A, De Garate E et al (2019) Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging 12:1973–1982
doi: 10.1016/j.jcmg.2018.12.023 pubmed: 30772224
Vágó H, Szabó L, Dohy Z et al (2020) Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries. Heart 106:992–1000
doi: 10.1136/heartjnl-2019-316295 pubmed: 32447308
Sörensson P, Ekenbäck C, Lundin M et al (2021) Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries. JACC Cardiovasc Imaging 14:1774–1783
doi: 10.1016/j.jcmg.2021.02.021 pubmed: 33865778
Monney PA, Sekhri N, Burchell T et al (2011) Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart 97:1312–1318
doi: 10.1136/hrt.2010.204818 pubmed: 21106555
Dastidar AG, Harries I, Pontecorboli G et al (2019) Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique. Int J Cardiovasc Imaging 35:517–527
doi: 10.1007/s10554-018-1467-1 pubmed: 30357547
Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72:3158–3176
doi: 10.1016/j.jacc.2018.09.072 pubmed: 30545455
Vermes E, Berradja N, Saab I et al (2020) Cardiac magnetic resonance for assessment of cardiac involvement in takotsubo syndrome: do we still need contrast administration? Int J Cardiol 308:93–95
doi: 10.1016/j.ijcard.2020.03.039 pubmed: 32247572
Baggiano A, Boldrini M, Martinez-Naharro A et al (2020) Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13:69–80
doi: 10.1016/j.jcmg.2019.03.026 pubmed: 31202744
Hirschberg K, Braun SM, Paul O, et al (2021) The diagnostic accuracy of truncated cardiovascular MR protocols for detecting non-ischemic cardiomyopathies. Int J Cardiovasc Imaging. https://doi.org/10.1007/s10554-021-02462-2
Kramer CM, Barkhausen J, Bucciarelli-Ducci C et al (2020) Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 22:17
doi: 10.1186/s12968-020-00607-1 pubmed: 32089132 pmcid: 7038611
Palmisano A, Benedetti G, Faletti R et al (2020) Early T1 myocardial MRI mapping: value in detecting myocardial hyperemia in acute myocarditis. Radiology 295:316–325
doi: 10.1148/radiol.2020191623 pubmed: 32154772
Lawson MA, Blackwell GG, Davis ND et al (1996) Accuracy of biplane long-axis left ventricular volume determined by cine magnetic resonance imaging in patients with regional and global dysfunction. Am J Cardiol 77:1098–1104
doi: 10.1016/S0002-9149(96)00140-3 pubmed: 8644665
Leiner T, Bogaert J, Friedrich MG et al (2020) SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 22:76
doi: 10.1186/s12968-020-00682-4 pubmed: 33161900 pmcid: 7649060
Nadjiri J, Zaschka A-L, Straeter AS et al (2019) Evaluation of a shortened cardiac MRI protocol for left ventricular examinations: diagnostic performance of T1-mapping and myocardial function analysis. BMC Med Imaging 19:57
doi: 10.1186/s12880-019-0358-9 pubmed: 31340756 pmcid: 6657063
Ferreira VM, Piechnik SK, Dall’Armellina E et al (2014) Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 16:36
doi: 10.1186/1532-429X-16-36 pubmed: 24886708 pmcid: 4041901
Gatti M, Carisio A, D’Angelo T et al (2020) Cardiovascular magnetic resonance in myocardial infarction with non-obstructive coronary arteries patients: a review. World J Cardiol 12:248–261
doi: 10.4330/wjc.v12.i6.248 pubmed: 32774777 pmcid: 7383353
Dang Y, Hou Y (2021) The prognostic value of late gadolinium enhancement in heart diseases: an umbrella review of meta-analyses of observational studies. Eur Radiol 31:4528–4537
doi: 10.1007/s00330-020-07437-w pubmed: 33409800
Georgiopoulos G, Figliozzi S, Sanguineti F et al (2021) Prognostic impact of late gadolinium enhancement by cardiovascular magnetic resonance in myocarditis: a systematic review and meta-analysis. Circ Cardiovasc Imaging 14:e011492
doi: 10.1161/CIRCIMAGING.120.011492 pubmed: 33441003
Yang M-X, Luo H-B, Liu J-K, et al (2022) Prognostic value of non-contrast myocardial T1 mapping in cardiovascular diseases: a systematic review and meta-analysis. Heart Fail Rev 27:1899–1909
Snel GJH, van den Boomen M, Hernandez LM et al (2020) Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis. J Cardiovasc Magn Reson 22:34
doi: 10.1186/s12968-020-00627-x pubmed: 32393281 pmcid: 7212597
Ghadri J-R, Wittstein IS, Prasad A et al (2018) International expert consensus document on takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39:2032–2046
doi: 10.1093/eurheartj/ehy076 pubmed: 29850871 pmcid: 5991216
Huttin O, Petit M-A, Bozec E et al (2015) Assessment of left ventricular ejection fraction calculation on long-axis views from cardiac magnetic resonance imaging in patients with acute myocardial infarction. Medicine (Baltimore) 94:e1856
doi: 10.1097/MD.0000000000001856 pubmed: 26512596

Auteurs

Marco Gatti (M)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy. m.gatti@unito.it.

Anna Palmisano (A)

Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Mattia Gerboni (M)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy.

Riccardo Cau (R)

Department of Radiology, AOU Cagliari, University of Cagliari, Cagliari, Italy.

Alessandra Pintus (A)

Department of Radiology, AOU Cagliari, University of Cagliari, Cagliari, Italy.

Michele Porcu (M)

Department of Radiology, AOU Cagliari, University of Cagliari, Cagliari, Italy.

Davide Tore (D)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy.

Davide Vignale (D)

Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Alessandro Andreis (A)

Division of Cardiology, Department Cardiovascular and Thoracic, Città Della Salute E Della Scienza Hospital, University of Turin, Turin, Italy.

Laura Bergamasco (L)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy.

Gaetano Maria De Ferrari (GM)

Division of Cardiology, Department Cardiovascular and Thoracic, Città Della Salute E Della Scienza Hospital, University of Turin, Turin, Italy.

Antonio Esposito (A)

Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Luca Saba (L)

Department of Radiology, AOU Cagliari, University of Cagliari, Cagliari, Italy.

Paolo Fonio (P)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy.

Riccardo Faletti (R)

Radiology Unit, Department of Surgical Sciences, University of Turin, Via Genova 3, 10126, Turin, Italy.

Classifications MeSH